Cold, Cough and Sore Throat Remedies Market Analysis Will Expand at a CAGR of 3.2% from 2016-2026
Verfasser: pradnya_86 on Wednesday, 19 April 2017The oral syrups segment is expected to dominate the global cold, cough and sore throat remedies market in the coming decade
Oral syrups segment is expected to expand at 2.9% CAGR over the estimated period and be valued more than US$ 10 Bn by the end of 2026. The segment is expected to create absolute $ opportunity of a little more than US$ 300 Mn in 2017 over 2016. The segment is the most acceptable dosage form for cough, cold, and sore throat medicines due to ease of administration and pleasant taste. The oral syrups segment dominated the global cold, cough and sore throat remedies market in terms of revenue in 2016 and the trend is projected to continue throughout the forecast period. Oral syrups segment is the most attractive segment, with attractiveness index of 1.5 over the forecast period.
Pleasant taste and easy intake of oral syrups are the key factors boosting segmental growth during the forecast period